Molecular Characterization of Squamous Cell Carcinomas From Recessive Dystrophic Epidermolysis Bullosa

Abstract

Patients with recessive dystrophic epidermolysis bullosa (ROEB) frequently present with squamous cell carcinomas (SCCs) probably as a result of chronic blistering and extensive scarring. These tumors are clinically aggressive as they metastasize readily. The metastasis-associated protein (MTA)-1, a transcription suppressor, is overexpressed in several epithelial neoplasms including SCCs. Our preliminary results demonstrate that MTA1 expression is induced by activation of the epidermal growth factor receptor (EGFR). As deregulation of EGFR signaling is frequently observed in aggressive epithelial neoplasms we propose to study the role of EGFR signaling and MTA1 expression in SCCs derived in ROEB patients. Our Specific Aims are to establish cell lines derived from SCCs in non-ROEB and ROEB patients, characterize the malignant phenotype of these cells as it relates to EGFR expression and signaling and to expression of MTA1, examine the contribution of EGFR/MTA1 to proliferation, invasiveness, and cell survival and identity EGFRdependent signaling pathways contributing to MTA1 expression in these cells. The results from this research will provide invaluable tools for future analysis of the pathology of carcinoma cells and will ascertain whether EGFR/MTA1 signaling pathways contributes significantly to the metastasis and invasiveness of SCC derived from ROEB patients.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2006
Accession Number
ADA463709

Entities

People

  • Jouni Uitto
  • My G. Mahoney
  • Ulrich Rodeck

Organizations

  • Thomas Jefferson University

Tags

DTIC Thesaurus Topics

  • Cell Physiological Processes
  • Cells
  • Chemical Synthesis
  • Chemistry
  • Epidermis
  • Genetics
  • Health Services
  • Indicator Dyes
  • Intercellular Junctions
  • Peptide Growth Factors

Readers

  • Molecular Biology and Genetics
  • Molecular and Cellular Biology
  • Trauma Surgery or Emergency Medicine.